LIfT BioSciences Secures €12M Grant to Advance Neutrophil-Based Cancer Therapy into Clinical Trials
LIfT BioSciences has been awarded a €12 million grant from Ireland’s Disruptive Technologies Innovation Fund (DTIF) to progress its Immuno-Modulatory Alpha Neutrophils (IMAN) therapy into…
